glp-1 receptor agonist dry eye New Medication Class Debuts As the use of GLP-1
Description
That future remains far away
"No one should ever be exposed to those risks, and we urge FDA and other regulators to stop this unlawful activity before more people get hurt."
A.MaesA.LiuQ.Johnson-LevonasA
GLP-1RAs not only have the potential to treat the above-mentioned diseases but also ameliorate the co-morbidities simultaneously, which is important for patients with autoimmune/autoinflammatory diseases combined with metabolic diseases
The Street
